These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 39281376)

  • 1. Clinical value of ACR O-RADS combined with CA125 in the risk stratification of adnexal masses.
    Pan RK; Zhang SQ; Zhang XY; Xu T; Cui XW; Li R; Yu M; Zhang B
    Front Oncol; 2024; 14():1369900. PubMed ID: 39281376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses.
    Shi Y; Li H; Wu X; Li X; Yang M
    J Ovarian Res; 2023 Aug; 16(1):153. PubMed ID: 37537697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IETA Ultrasonic Features Combined with GI-RADS Classification System and Tumor Biomarkers for Surveillance of Endometrial Carcinoma: An Innovative Study.
    Lin D; Wang H; Liu L; Zhao L; Chen J; Tian H; Gao L; Wu B; Zhang J; Guo X; Hao Y
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428723
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses.
    Xie WT; Wang YQ; Xiang ZS; Du ZS; Huang SX; Chen YJ; Tang LN
    J Ovarian Res; 2022 Jan; 15(1):15. PubMed ID: 35067220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment.
    Zhu Q; Luo H; Middleton WD; Itani M; Hagemann IS; Hagemann AR; Hoegger MJ; Thaker PH; Kuroki LM; McCourt CK; Mutch DG; Powell MA; Siegel CL
    Ultrasound Obstet Gynecol; 2023 Dec; 62(6):891-903. PubMed ID: 37606287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of IOTA SR and O-RADS combined with CA125, HE4, and risk of malignancy algorithm to distinguish benign and malignant adnexal masses.
    Yang Y; Ju H; Huang Y
    Eur J Radiol; 2023 Aug; 165():110926. PubMed ID: 37418798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): Analysis on 1054 adnexal masses.
    Cao L; Wei M; Liu Y; Fu J; Zhang H; Huang J; Pei X; Zhou J
    Gynecol Oncol; 2021 Jul; 162(1):107-112. PubMed ID: 33966893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of O-RADS combined with serum CA125 and HE4 for the diagnosis of ovarian tumours.
    Wang R; Li X; Li S; Fang S; Zhao C; Yang H; Yang Z
    Acta Radiol; 2023 Feb; 64(2):821-828. PubMed ID: 35291856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the diagnostic efficacy of O-RADS in adnexal masses.
    Su N; Yang Y; Liu Z; Gao L; Dai Q; Li J; Wang H; Jiang Y
    Sci Rep; 2023 Sep; 13(1):15667. PubMed ID: 37735610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
    Hiett AK; Sonek JD; Guy M; Reid TJ
    Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram based on the O-RADS for predicting the malignancy risk of adnexal masses with complex ultrasound morphology.
    Gong LP; Li XY; Wu YN; Dong S; Zhang S; Feng YN; Lv YE; Guo XJ; Peng YQ; Du XS; Tian JW; Sun CX; Sun LT
    J Ovarian Res; 2023 Mar; 16(1):57. PubMed ID: 36945000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of American College of Radiology Ovarian-Adnexal Reporting and Data System ultrasound to predict malignancy risk in adnexal lesions.
    Li Y; Shao G; Wu M; Zhang F; Zhang Y; Shao C
    J Obstet Gynaecol Res; 2024 Feb; 50(2):225-232. PubMed ID: 37990446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive accuracy and reproducibility of the O-RADS US scoring system among sonologists with different training levels.
    Wu M; Zhang M; Cao J; Wu S; Chen Y; Luo L; Lin X; Su M; Zhang X
    Arch Gynecol Obstet; 2023 Aug; 308(2):631-637. PubMed ID: 35994107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Ultrasound Scores (Subjective Assessment, Simple Rules Risk Assessment, ADNEX Model, O-RADS) to Adnexal Masses of Difficult Classification.
    Pelayo M; Sancho-Sauco J; Sánchez-Zurdo J; Perez-Mies B; Abarca-Martínez L; Cancelo-Hidalgo MJ; Sainz-Bueno JA; Alcázar JL; Pelayo-Delgado I
    Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the diagnostic value of using serum CA125 and GI-RADS system in the evaluation of adnexal masses.
    Zheng H; Tie Y; Wang X; Yang Y; Wei X; Zhao X
    Medicine (Baltimore); 2019 Feb; 98(7):e14577. PubMed ID: 30762809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the O-RADS and ADNEX models regarding malignancy rate and validity in evaluating adnexal lesions.
    Chen GY; Hsu TF; Chan IS; Liu CH; Chao WT; Shih YC; Jiang LY; Chang YH; Wang PH; Chen YJ
    Eur Radiol; 2022 Nov; 32(11):7854-7864. PubMed ID: 35583711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Combing O-RADS US and CA-125 Improve Diagnostic Accuracy in Assessing Adnexal Malignancy Risk in Women With Different Menopausal Status?
    Wu M; Wang Q; Zhang M; Cao J; Chen Y; Zheng J; Luo L; Su M; Lin X; Kuang X; Zhang X
    J Ultrasound Med; 2023 Feb; 42(3):675-685. PubMed ID: 35880406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.
    Yoeli-Bik R; Longman RE; Wroblewski K; Weigert M; Abramowicz JS; Lengyel E
    JAMA Netw Open; 2023 Jul; 6(7):e2323289. PubMed ID: 37440228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Diagnostic Efficacy of the International Ovarian Tumor Analysis ADNEX Model and the ACR O-RADS US (Ovarian-Adnexal Reporting and Data System) for Benign and Malignant Ovarian Tumors: A Retrospective Study in a Tumor Center in Northeast China.
    Zhong D; Gao XQ; Li HX; Wang HB; Liu Y
    J Imaging Inform Med; 2024 Jul; ():. PubMed ID: 38977614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modified CEUS risk stratification model for adnexal masses with solid components: prospective multicenter study and risk adjustment.
    Wu M; Zhang M; Qu E; Sun X; Zhang R; Mu L; Xiao L; Wen H; Wang R; Liu T; Meng X; Wu S; Chen Y; Su M; Wang Y; Gu J; Zhang X
    Eur Radiol; 2024 Sep; 34(9):5978-5988. PubMed ID: 38374482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.